Who cannot take Strattera?

Who Cannot Take Strattera?
Strattera, known generically as atomoxetine, is a non-stimulant medication primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD) in both children and adults. While it can be an effective treatment option, there are specific groups of individuals who should avoid taking Strattera due to potential health risks and contraindications.
1. Individuals with Severe Cardiovascular Conditions
Patients with serious cardiovascular issues, such as heart disease, high blood pressure, or arrhythmias, should not take Strattera. The medication can increase heart rate and blood pressure, which may exacerbate these conditions. Therefore, a thorough cardiovascular assessment is essential before prescribing Strattera to ensure patient safety.
2. Those with a History of Allergic Reactions
Anyone who has experienced an allergic reaction to atomoxetine or any of its components should avoid using Strattera. Allergic reactions can manifest as skin rashes, itching, or more severe symptoms like difficulty breathing. It is crucial for patients to disclose any known allergies to their healthcare provider prior to starting treatment.
3. Patients Taking Monoamine Oxidase Inhibitors (MAOIs)
Strattera should not be taken concurrently with monoamine oxidase inhibitors, a class of medications used to treat depression and anxiety. The combination can lead to serious side effects, including hypertensive crises, which are dangerous spikes in blood pressure. Patients must wait at least 14 days after discontinuing an MAOI before starting Strattera.
4. Individuals with Glaucoma
Those diagnosed with narrow-angle glaucoma should avoid Strattera, as the medication can potentially increase intraocular pressure, worsening the condition. This is particularly important for patients who have a history of eye problems.
5. Patients with Liver Problems
Strattera is metabolized in the liver, and individuals with liver impairment may experience increased levels of the drug in their system, leading to heightened side effects or toxicity. Therefore, patients with liver disease should be carefully evaluated, and alternative treatments may be considered.
6. Children Under Six Years Old
Strattera is not approved for use in children younger than six years. The safety and efficacy of the medication in this age group have not been established, making it essential for healthcare providers to consider age-appropriate alternatives for younger patients.
Conclusion
While Strattera can be a beneficial treatment for ADHD, it is not suitable for everyone. Individuals with severe cardiovascular conditions, a history of allergic reactions, those taking MAOIs, patients with glaucoma, individuals with liver problems, and children under six should avoid this medication. It is always advisable for patients to have an open dialogue with their healthcare provider to assess their specific health needs and determine the most appropriate treatment options.

What are the bad things about Strattera?

Strattera (atomoxetine) is a medication that treats ADHD (attention-deficit hyperactivity disorder). It has several side effects to be aware of. Some of the most common Strattera side effects are nausea, dry mouth, and decreased appetite. Sleep changes, constipation, and headaches are also possible.

Who shouldn’t take atomoxetine?

Atomoxetine may cause serious heart or blood vessel problems. This may be more likely in patients who have a family history of heart disease.

Does Strattera interact with anything?

Yes. Strattera can interact with certain selective serotonin reuptake inhibitors (SSRIs), causing an increased risk of side effects from Strattera. Examples include fluoxetine (Prozac) and paroxetine (Paxil).

How much weight did you lose on Strattera?

However, weight gain rebounds after this time and returns to normal. In one study, children who took Strattera for up to 9 weeks lost 0.5 kg on average. Another small study showed that women identified as obese who took Strattera for 12 weeks lost 3.6 kg on average.

Why is Strattera being discontinued?

As of November 2023, the drug manufacturer, Eli Lilly, discontinued all strengths of Strattera due to declining sales after the generic version came out in 2017. The generic drug, atomoxetine, is still available. One reason to consider trying atomoxetine is because it’s available.

What is the next step if Strattera doesn’t work?

What to Do if Medication Stops Working. If you’re taking ADHD medicine and your symptoms don’t improve or they get worse, tell your doctor. They may recommend that you slowly increase your dose. If that doesn’t work, you may have to try a different drug.

Does Strattera not work for some people?

As a result, some patients give up before one month because it doesn’t seem to work. If an individual needs ADHD medication only occasionally, for example, to improve focus and attention for a short period, taking Strattera may not be the best option.

What is the new alternative to Strattera?

Strattera (atomoxetine) is the most well-studied and effective non-stimulant ADHD medication for adults and children ages 6 and older. But Qelbree, a newer ADHD medication, works in a similar way.

Is Strattera hard on your heart?

The TGA is advising health professionals and patients of important safety information regarding the risk of increased blood pressure and/or heart rate with the use of atomoxetine (STRATTERA®). These effects could represent a risk for some patients.

When should you not take Strattera?

Tell your doctor if you
are involved in strenuous exercise or activities • are using a group of medicines called stimulants • have a family history of sudden/cardiac death. STRATTERA generally should not be used in children, adolescents or adults with known structural heart abnormalities.